<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of ablative intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (50 mg/kg per day for 4 days) without stem cell rescue has been described in patients with refractory <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> such as <z:e sem="disease" ids="C1112570" disease_type="Neoplastic Process" abbrv="">paraneoplastic pemphigus</z:e>, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a 33-year-old patient with <z:e sem="disease" ids="C0030809" disease_type="Disease or Syndrome" abbrv="">pemphigus vulgaris</z:e> recalcitrant to multiple therapies </plain></SENT>
<SENT sid="2" pm="."><plain>The patient presented with numerous <z:e sem="disease" ids="C0149745" disease_type="Disease or Syndrome" abbrv="">oral ulcerations</z:e>, <z:mpath ids='MPATH_580'>erosions</z:mpath>, and hyperpigmented crusted plaques on his face, trunk, and arms </plain></SENT>
<SENT sid="3" pm="."><plain>Findings of a skin biopsy and direct immunofluorescence were consistent with <z:e sem="disease" ids="C0030809" disease_type="Disease or Syndrome" abbrv="">pemphigus vulgaris</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The circulating <z:e sem="disease" ids="C0030809" disease_type="Disease or Syndrome" abbrv="">pemphigus vulgaris</z:e> autoantibodies were present at a titer of 1:640 </plain></SENT>
<SENT sid="5" pm="."><plain>The patient received immunoablative therapy (50 mg/kg of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> for a total of 4 days) and tolerated the regimen well </plain></SENT>
<SENT sid="6" pm="."><plain>Complications such as <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and Pseudomonas <z:mpath ids='MPATH_681'>septicemia</z:mpath> were quickly treated </plain></SENT>
<SENT sid="7" pm="."><plain>Four months after the 4-day therapy, his oral and <z:mp ids='MP_0001212'>skin lesions</z:mp> completely healed, and his <z:e sem="disease" ids="C0030807" disease_type="Disease or Syndrome" abbrv="">pemphigus</z:e> titers have decreased to zero </plain></SENT>
<SENT sid="8" pm="."><plain>He is no longer receiving <z:chebi fb="0" ids="8382">prednisone</z:chebi> and no new lesions have developed </plain></SENT>
<SENT sid="9" pm="."><plain>This provides further evidence that this regimen is relatively safe and provides a potential "cure" for refractory <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> such as <z:e sem="disease" ids="C0030809" disease_type="Disease or Syndrome" abbrv="">pemphigus vulgaris</z:e> </plain></SENT>
</text></document>